Skip to main content

Chemo Causes Nerve Pain For Many Cancer Patients

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 29, 2025.

By Dennis Thompson HealthDay Reporter

WEDNESDAY, Jan. 29, 2025 -- Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review suggests.

These patients might experience loss of balance and coordination, weakness or sensations of numbness, tingling, “pins and needles,” or burning, researchers said in a study published Jan. 28 in the journal Regional Anesthesia & Pain Medicine.

“Our findings emphasize that chronic painful chemotherapy-induced peripheral neuropathy represents a substantial global health challenge, affecting more than 40% of those diagnosed,” concluded the research team led by Dr. Ryan D’Souza, an anesthesiologist with the Mayo Clinic in Rochester, Minn.

Platinum-based or taxane chemotherapy drugs appear to pose the greatest risk for nerve pain, and lung cancer patients seem to have the highest rates of neuropathy, results show.

Chemo drugs kill cancer but also damage healthy cells and tissues, including those of the nervous system, researchers said in background notes.

Peripheral neuropathy is a known potential side effect of chemotherapy, but this study is the first to estimate how common it is among cancer patients.

The condition is thought to be caused by chemo drug damage that disrupts or rewires normal nerve signaling, resulting in persistent pain, researchers said.

For the study, researchers pooled the results of 77 previous studies involving nearly 11,000 participants from 28 countries.

The data revealed that just over 41% of patients treated with chemo developed painful and persistent peripheral neuropathy that lasted at least three months.

Nearly 41% of patients treated with platinum-based chemo developed nerve pain, as well as just over 38% of those treated with taxanes, results show.

Nerve pain was most common in lung cancer patients, affecting more than 62%. This is probably because these patients frequently require multiple and prolonged cycles of chemo.

People treated for ovarian cancer (32%) and lymphoma (36%) had the lowest risk.

Researchers said future study should focus on how chemo specifically causes nerve pain, and on developing therapies that can protect cancer patients who are receiving the lifesaving treatment.

Sources

  • BMJ Journals, news release, Jan. 28, 2025

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted January 2025

Read this next

Weight-Loss Drugs May Lower Risk Of Obesity-Related Cancers

WEDNESDAY, May 28, 2025 — Popular GLP-1 weight loss drugs like Ozempic and Zepbound can help reduce a woman’s risk for as many as 14 cancers associated with obesity, a...

Exercise Improves Odds Against Cancer

TUESDAY, May 27, 2025 -- The last thing a cancer patient might like to do is hit the treadmill or hop on an exercise bike, given how much the disease and its treatments drain a...

Alcohol-Related Cancer Deaths Double In The U.S.

FRIDAY, May 23, 2025 — Alcohol-fueled cancer deaths nearly doubled in the United States during the past three decades, with cases among men driving this surge, a new study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.